What is GenoPalate?
GenoPalate, Inc. operates at the intersection of biotechnology and consumer wellness, specializing in the field of nutritional genomics. The company provides a comprehensive ecosystem for health optimization, utilizing proprietary at-home DNA testing to deliver actionable dietary insights. By integrating these genetic markers with professional guidance from registered dietitians and bespoke supplement regimens, GenoPalate bridges the gap between complex scientific data and daily nutritional habits. Its market position is defined by a commitment to evidence-based research, positioning the brand as a leader in the burgeoning personalized nutrition sector. The company's ability to translate intricate biological information into user-friendly, health-conscious programs has established it as a key player in the preventative healthcare market.
How much funding has GenoPalate raised?
GenoPalate has raised a total of $9.8M across 3 funding rounds:
Series A
$4M
Other Financing Round
$5.6M
Stock/Share Issuance
$250K
Series A (2020): $4M, investors not publicly disclosed
Other Financing Round (2022): $5.6M, investors not publicly disclosed
Stock/Share Issuance (2026): $250K, investors not publicly disclosed
Key Investors in GenoPalate
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for GenoPalate?
With the successful closure of this latest financing round, GenoPalate is well-positioned to accelerate its enterprise-level expansion. The strategic allocation of these funds will likely focus on enhancing the company's digital infrastructure, expanding its research and development capabilities in nutrigenomics, and scaling its personalized supplement delivery platform. As the demand for data-driven health solutions continues to rise, GenoPalate is poised to leverage its current momentum to capture a larger share of the global wellness market. Future initiatives will likely prioritize the integration of machine learning algorithms to further refine nutritional recommendations, ensuring that the company remains at the forefront of the personalized health revolution while maintaining its rigorous standards for scientific accuracy and consumer privacy.
See full GenoPalate company page
